Pfizer Tasks “Established Products Unit” With Extending Life Of Mature Drugs

As Pfizer faces a future without several key blockbuster drugs, Lipitor among them, the company is setting out to extend the life of its mature franchises with the formation of a dedicated business unit for established brands